Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary wholesaler bought by US company
Patterson Companies acquires National Veterinary Services

The UK's largest veterinary distributor, National Veterinary Services (NVS), has been conditionally sold to US firm, Patterson Companies.

Patterson Companies, which supplies dental and diagnostic products, vaccines, veterinary equipment and pharmaceuticals, is to acquire all outstanding shares of NVS for £87.5million.

Wholly owned by Dechra Pharmaceuticals, NVS is reported to have had revenues of more than £315million for the year ended June 30, 2013.

As NVS becomes a stand-alone subsidiary of Patterson Companies, the UK wholesaler's current managing director, Martin Riley, will continue in his role which he has held for eight years.

Commenting on the development, CEO of Dechra Ian Page, said: "It will create a focused, international, branded veterinary products business, with the resources to pursue further organic and acquisitive growth and thereby generate increased value for shareholders…

"I believe that Patterson's international presence and sole focus on services will ensure a strong future for these businesses."

The agreement is subject to approval by Dechra shareholders and the closing date has been set for the middle of this month (August).

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'